The Effect of Whey Protein Supplementation on Vascular and Cognitive Function in Older Adults



Status:Completed
Conditions:High Blood Pressure (Hypertension)
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:60 - 85
Updated:10/6/2017
Start Date:October 2013
End Date:December 2016

Use our guide to learn which trials are right for you!

The Effect of Whey Protein Supplementation on Cerebrovascular and Cognitive Function in Older Adults

The "hardening of the arteries" observed with aging raises blood pressure and contributes to
poor brain blood flow and loss of cognitive function (i.e. attention, memory, solving
problems, making decisions). Cognition is the most important determinant of overall health
status, quality of life, functional ability and independence in older adulthood.
Nutraceutical strategies have received considerable attention as they may improve
cardiovascular health with far fewer side effects compared to drugs. In this regard, dairy
products are particularly attractive. Higher dairy consumption is associated with lower blood
pressure and improved memory in adults. Milk proteins have natural blood pressure lowering
effects. Studies conducted in animals have demonstrated that whey protein (a component of
milk protein) may also increase artery elasticity. This is important given the strong
association between artery elasticity, brain blood flow, and risk for cognitive decline.

The investigators propose to conduct a randomized double-blind placebo controlled study
comparing the effects of whey protein supplementation or carbohydrate placebo on measures of
artery elasticity, brain blood flow, and cognitive function in older adults. Whey protein may
be a novel dietary therapy to improve both artery health and brain health in older adults.

Participants will be randomly assigned to receive either 50 g whey protein isolate or placebo
each day for 12 weeks.

Inclusion Criteria:

- ages of 60-85 years

Exclusion Criteria:

- acute or terminal illness

- Montreal Cognitive Assessment < 26 (indicating dementia)

- myocardial infarction or stroke in the previous 6 months or other symptomatic coronary
or peripheral artery disease

- type I or type II diabetes mellitus

- visual impairment

- upper or lower extremity fracture in the previous 6 months

- uncontrolled hypertension (150/90 mm Hg)

- cigarette smoking

- chronic kidney disease (albumin/creatinine ratio (ACR) between 30-300 ug albumin/mg
creatinine)

- liver disease

- chronic pulmonary/respiratory disease

- body mass index (kg/m2) < 21 or > 32

- recent weight loss or gain greater than 7.5% of body weight within the previous 6
months

- currently supplementing diet with whey protein products

- milk-protein allergy, or allergy to para-aminobenzoic acid (PABA)

- head injury or symptoms of concussion in the past 3 months
We found this trial at
1
site
Syracuse, New York 13244
Principal Investigator: Kevin S Heffernan, Ph.D.
Phone: 315-443-9801
?
mi
from
Syracuse, NY
Click here to add this to my saved trials